We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
- Authors
Heiss, Gerardo; Wallace, Robert; Anderson, Garnet L; Aragaki, Aaron; Beresford, Shirley A A; Brzyski, Robert; Chlebowski, Rowan T; Gass, Margery; LaCroix, Andrea; Manson, JoAnn E; Prentice, Ross L; Rossouw, Jacques; Stefanick, Marcia L; WHI Investigators
- Abstract
The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits.
- Publication
JAMA, 2008, Vol 299, Issue 9, p1036
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.299.9.1036